Sign in

CIK 0001752828

  • Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831702591
Phone
+1 908-768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Shares withheld for taxes Chief Medical Officer gave up 52,762 shares (to pay taxes)
  4. 4 Shares withheld for taxes Haines John R gave up 70,350 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 43,968 shares (to pay taxes)
  6. 4 Shares withheld for taxes Pres, Functional Regeneration gave up 32,720 shares (to pay taxes)
  7. 4 Shares withheld for taxes Fletcher Kyle gave up 39,571 shares (to pay taxes)
  8. 4 Open-market buy 10% owner bought 21,410,983 shares at $0.25 ($5,331,335)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Chief Executive Officer bought 18,422,124 shares at an average $0.16 ($2,984,294)
  12. 4 Open-market sale 10% owner sold 15,371,697 shares
  13. 4 Grant or award Chief Medical Officer acquired 875,000 shares (grant or award)
  14. 4/A Shares withheld for taxes Director gave up 10,844 shares (to pay taxes)
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Director acquired 199,921 shares (grant or award)
  17. 4 Grant or award Director acquired 199,921 shares (grant or award)
  18. 4 Grant or award Director acquired 199,921 shares (grant or award)
  19. 4 Grant or award Director acquired 199,921 shares (grant or award)
  20. 4 Grant or award Director acquired 199,921 shares (grant or award)

Page 4 of 10 · 191 filings